Back to 
Miller Value Partners, LLC
Miller Value Partners, LLC
HALO
Showing 0 of 6 quarters
Position history for Miller Value Partners, LLC's holdings in Halozyme Therapeutics, Inc.
No. Miller Value Partners exited its HALO (Halozyme Therapeutics) position in Q1 2020. Its Q4 2019 13F listed 20,000 shares worth $355,000. Miller Value Partners already held HALO in its Q4 2018 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.